HNN3.0

Project cooperationUpdated on 14 January 2026

HORIZON-HLTH-2026-01-DISEASE-03

Researcher at IDENER R&D

Sevilla, Spain

About

Our initiative addresses the escalating public health and economic challenges posed by long-term post-infectious conditions, which often lead to persistent inflammation, organ damage, and impaired functional capacity. We aim to develop a multidisciplinary framework that bridges the gap between understanding disease pathophysiology and implementing practical, innovative management strategies for patients. To achieve this, we are seeking partners with the capacity to provide relevant patient cohorts and expertise in identifying protective or risk factors by integrating genetic, immune, and inflammatory data.

At the core of our technical approach is the integration of biomarkers and validated diagnostic tools for early detection and treatment optimization. We intend to incorporate advanced computational modeling to predict disease risk and progression across diverse populations. Furthermore, we are looking for collaborators to design and validate preventive and therapeutic interventions through early-stage clinical trials that demonstrate clinical safety and efficacy. To ensure a holistic recovery, our project will also prioritize effective supportive rehabilitation, including physical, cognitive, and psychological interventions to enhance the quality of life for those affected.

A distinctive feature of our proposal is the strong emphasis on sex and gender differences, as well as the inclusion of vulnerable populations and groups with pre-existing conditions to ensure equitable healthcare solutions. By involving social sciences and humanities (SSH) experts, we aim to examine best practices for integrating post-infectious disease management effectively into primary and specialized healthcare settings. Finally, our commitment to European research standards includes a harmonized approach to FAIR data sharing through the European Health Data Space (EHDS) and early engagement with the European Medicines Agency (EMA) to ensure the regulatory adequacy of our actions.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions

Type

  • Consortium/Coordinator seeks Partners

Organisation

IDENER R&D

R&D Institution

Seville, Spain

Similar opportunities

  • Project cooperation

    POST-INFECT AI TWIN AI-powered prediction, diagnosis support and personalised management of post-infection long-term conditions

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions

    Fabrizio Coccetti

    Project Manager at Acube srl

    Teramo, Italy

  • Project cooperation

    GeoSpreadAI

    • Partner seeks Consortium/Coordinator
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Anastasiya Babintseva

    Professor of the Department of Pediatrics, Neonatology and Perinatal Medicine at Bukovinian State Medical University

    Chernivtsi, Ukraine

  • Project cooperation

    International Health & Infectious Diseases Unit seeking Horizon Europe Cluster Health partners (2026)

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-05: Support for a multilateral initiative on climate change and health research
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Laura Soldevila

    physician at Fundació LLuita contra les Infeccions

    Badalona, Spain